scholarly article | Q13442814 |
P356 | DOI | 10.1038/ONC.2011.86 |
P8608 | Fatcat ID | release_qqhi5pbkjvdijnb3smxrumn37m |
P932 | PMC publication ID | 3134560 |
P698 | PubMed publication ID | 21423209 |
P5875 | ResearchGate publication ID | 50596741 |
P2093 | author name string | L James | |
S P Monga | |||
P K Wagh | |||
S E Waltz | |||
G M Zinser | |||
J K Gray | |||
J Vasiliauskas | |||
P2860 | cites work | Epidermal growth factor receptor regulates beta-catenin location, stability, and transcriptional activity in oral cancer | Q24304061 |
Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression | Q24633875 | ||
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei | Q27860728 | ||
beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin | Q28190343 | ||
Balancing cell adhesion and Wnt signaling, the key role of beta-catenin | Q28288763 | ||
Tyrosine residues 654 and 670 in beta-catenin are crucial in regulation of Met-beta-catenin interactions | Q28577530 | ||
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer | Q29547699 | ||
Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family member | Q33257955 | ||
The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells | Q33592512 | ||
Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance | Q33903965 | ||
Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway | Q33969327 | ||
Ron receptor tyrosine kinase activation confers resistance to tamoxifen in breast cancer cell lines | Q34041328 | ||
Frequent overexpression of epidermal growth factor receptor (EGFR) in mammary high grade ductal carcinomas with myoepithelial differentiation | Q35588886 | ||
Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression | Q35679187 | ||
The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans | Q35758261 | ||
beta-Catenin signaling in biological control and cancer. | Q36939963 | ||
Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer. | Q37293205 | ||
The Ron receptor tyrosine kinase negatively regulates mammary gland branching morphogenesis | Q37308684 | ||
The beta-catenin axis integrates multiple signals downstream from RET/papillary thyroid carcinoma leading to cell proliferation. | Q37351482 | ||
Key signalling nodes in mammary gland development and cancer: Myc. | Q37467223 | ||
Targeting Wnt signaling: can we safely eradicate cancer stem cells? | Q37763415 | ||
A novel RET kinase-beta-catenin signaling pathway contributes to tumorigenesis in thyroid carcinoma. | Q40006287 | ||
A physiologic imaging pilot study of breast cancer treated with AZD2171. | Q40333245 | ||
Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients. | Q40443024 | ||
Overexpression of the RON gene in human breast carcinoma | Q41023826 | ||
Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice | Q41400379 | ||
Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis | Q42824776 | ||
Ron receptor signaling augments mammary tumor formation and metastasis in a murine model of breast cancer | Q45285566 | ||
beta-Catenin and met deregulation in childhood Hepatoblastomas | Q46741023 | ||
Regulation of E-cadherin/Catenin association by tyrosine phosphorylation. | Q52537297 | ||
Mammary-specific Ron receptor overexpression induces highly metastatic mammary tumors associated with beta-catenin activation | Q57100119 | ||
Growth factor expression in Breast tissue | Q57581209 | ||
Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice | Q79152321 | ||
Study of phospho-beta-catenin subcellular distribution in invasive breast carcinomas in relation to their phenotype and the clinical outcome | Q82536206 | ||
beta-catenin gene mutation in invasive ductal breast cancer | Q83189139 | ||
P433 | issue | 34 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 3694-3704 | |
P577 | publication date | 2011-03-21 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | β-Catenin is required for Ron receptor-induced mammary tumorigenesis | |
P478 | volume | 30 |
Q39289235 | CBP/Catenin antagonists: Targeting LSCs' Achilles heel |
Q36188917 | CD151 represses mammary gland development by maintaining the niches of progenitor cells. |
Q35591995 | Can we safely target the WNT pathway? |
Q37109753 | Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression. |
Q38980169 | Collective cell migration of primary zebrafish keratocytes |
Q35986081 | Conditional deletion of β-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis. |
Q47403872 | Delayed Sequential Co-Delivery of Gefitinib and Doxorubicin for Targeted Combination Chemotherapy. |
Q35777328 | Estrogen receptor alpha deletion enhances the metastatic phenotype of Ron overexpressing mammary tumors in mice |
Q37708952 | FOXC1 promotes melanoma by activating MST1R/PI3K/AKT. |
Q90835372 | Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells |
Q36232073 | HGFL supports mammary tumorigenesis by enhancing tumor cell intrinsic survival and influencing macrophage and T-cell responses. |
Q41708922 | HGFL-mediated RON signaling supports breast cancer stem cell phenotypes via activation of non-canonical β-catenin signaling. |
Q35025393 | Intron retention in the alternatively spliced region of RON results from weak 3' splice site recognition |
Q38786359 | Kat3 coactivators in somatic stem cells and cancer stem cells: biological roles, evolution, and pharmacologic manipulation. |
Q38116308 | MSP-RON signalling in cancer: pathogenesis and therapeutic potential |
Q58089109 | Macrophage Stimulating Protein (MSP) Preserves Blood Brain Barrier Integrity After Intracerebral Hemorrhage Through RON Dependent GAB1/Src/β-catenin Pathway Activation in a Mouse Model |
Q52938678 | Myoepithelial and luminal breast cancer cells exhibit different responses to all-trans retinoic acid. |
Q26864275 | Pathogenesis of RON receptor tyrosine kinase in cancer cells: activation mechanism, functional crosstalk, and signaling addiction |
Q64941091 | RON and RONΔ160 promote gastric cancer cell proliferation, migration, and adaption to hypoxia via interaction with β-catenin. |
Q36206487 | RanBPM expression regulates transcriptional pathways involved in development and tumorigenesis. |
Q35577352 | Ron receptor overexpression in the murine prostate induces prostate intraepithelial neoplasia |
Q33764576 | Ron receptor signaling is protective against DSS-induced colitis in mice. |
Q27003295 | Ron receptor tyrosine kinase signaling as a therapeutic target |
Q38224211 | Safely targeting cancer stem cells via selective catenin coactivator antagonism |
Q47138564 | Sequential delivery of erlotinib and doxorubicin for enhanced triple negative Breast cancer treatment using polymeric nanoparticle. |
Q33836444 | Suppression Of β-catenin Nuclear Translocation By CGP57380 Decelerates Poor Progression And Potentiates Radiation-Induced Apoptosis in Nasopharyngeal Carcinoma |
Q34765982 | The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor-positive breast cancers |
Q36887780 | The RON receptor tyrosine kinase is a potential therapeutic target in Burkitt lymphoma |
Q35190869 | The Ron receptor promotes prostate tumor growth in the TRAMP mouse model. |
Q91673432 | Therapeutic Considerations for Ron Receptor Expression in Prostate Cancer |
Q58777826 | Tumor Cell Autonomous RON Receptor Expression Promotes Prostate Cancer Growth Under Conditions of Androgen Deprivation |
Q36140785 | Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity. |
Q36329477 | Wnt signaling in mammary glands: plastic cell fates and combinatorial signaling |